CLDI
Calidi Biotherapeutics, Inc.
+0.05 (+4.29%)1.22USD135K成交股數3.2M市值0.1本益比(近四季)70.1股價營收比–營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 2.6M | 2.6M | 2.4M | 2.6M | 2.4M | 1.8M | 2.2M | 2.2M | 2.7M | 3.3M | 3.2M | 2.6M |
| 銷售管理費用 | 1.6M | 1.6M | 2.7M | 3.1M | 2.6M | 2.2M | 3.1M | 3.6M | 4.0M | 4.0M | 3.4M | 2.8M |
| 營業利益 | −4.2M-18% | −4.2M+4% | −5.0M-3% | −5.7M-2% | −5.1M-25% | −4.0M-44% | −5.2M-20% | −5.8M+7% | −6.8M | −7.2M | −6.5M | −5.4M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −4.2M-17% | −4.1M+0% | −5.1M+2% | −5.7M-1% | −5.0M-31% | −4.1M+102% | −5.1M-60% | −5.8M-11% | −7.2M | −2.0M | −12.5M | −6.5M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -2.94+33% | -0.43-95% | -2.21-71% | -31.75+90% | -2.21+9% | -9.17+550% | -7.75-46% | -16.75+2133% | -2.03 | -1.41 | -14.24 | -0.75 |
| 稀釋股數 | 1.4M | 10.3M | 4.9K | 180K | 2.3M | 667 | 652 | 444 | 3.6K | 1.4M | 878K | 8.7M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 4.3M | 6.9M | 10.6M | 5.4M | 10.8M | 9.6M | 1.9M | 800K | 1.2M | 10.4M | 2.3M | 1.1M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | 870.00 | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 7.2M | 9.6M | 14.0M | 9.4M | 15.1M | 14.2M | 6.7M | 6.4M | 7.4M | 18.6M | 44.0M | 43.2M |
| 有息負債 | 600K | 600K | 600K | 600K | 600K | 600K | 2.4M | 1.9M | 3.4M | 2.0M | – | – |
| 總負債 | 4.1M | 4.7M | 6.8M | 7.3M | 7.8M | 12.2M | 16.5M | 18.2M | 22.0M | 19.7M | 12.8M | 8.2M |
| 股東權益 | 3.1M | 4.9M | 6.9M | 1.8M | 6.9M | 1.5M | −9.8M | −11.8M | −14.6M | −1.1M | −63.7M | −55.1M |
| 負債比 | 56.5% | 48.5% | 48.7% | 77.8% | 51.5% | 86.1% | 247.2% | 282.7% | 296.8% | 105.9% | 29.0% | 18.9% |
| 淨現金(現金 − 有息負債) | 3.7M | 6.3M | 10.0M | 4.8M | 10.2M | 9.0M | −473K | −1.1M | −2.2M | 8.4M | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −4.1M | – | – | −7.1M+86% | – | – | – | −3.8M | – | – | −3.1M |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | 426K | – | – | 394K | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −19.9M | –% | -5.95 | – |
| FY2024 | – | – | −22.1M | –% | -35.70 | – |
| FY2023 | – | – | −29.2M | –% | -17.33 | – |
| FY2022 | 45K | – | −25.4M | -56,504.4% | 2.99 | – |